Insider Transactions in Q1 2020 at Johnson & Johnson (JNJ)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2020
|
William D Perez Director |
BUY
Open market or private purchase
|
Direct |
500
+3.02%
|
$63,500
$127.69 P/Share
|
|
Feb 21
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct |
39,224
-52.27%
|
$5,765,928
$147.96 P/Share
|
|
Feb 21
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
19,224
+20.39%
|
$1,730,160
$90.44 P/Share
|
|
Feb 13
2020
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,393
-4.78%
|
$1,558,950
$150.46 P/Share
|
|
Feb 13
2020
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,231
+9.35%
|
-
|
|
Feb 13
2020
|
Robert J Decker VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
555
-2.01%
|
$83,250
$150.46 P/Share
|
|
Feb 13
2020
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,499
+5.24%
|
-
|
|
Feb 13
2020
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
43,904
-6.98%
|
$6,585,600
$150.46 P/Share
|
|
Feb 13
2020
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
105,668
+14.19%
|
-
|
|
Feb 13
2020
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
45,471
-4.67%
|
$6,820,650
$150.46 P/Share
|
|
Feb 13
2020
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
107,016
+9.98%
|
-
|
|
Feb 13
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
5,832
-5.3%
|
$874,800
$150.46 P/Share
|
|
Feb 13
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
13,747
+11.49%
|
-
|
|
Feb 13
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Payment of exercise price or tax liability
|
Direct |
1,444
-1.27%
|
$216,600
$150.46 P/Share
|
|
Feb 13
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
3,692
+3.17%
|
-
|
|
Feb 13
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,140
-4.29%
|
$771,000
$150.46 P/Share
|
|
Feb 13
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,836
+9.23%
|
-
|
|
Feb 13
2020
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
16,101
-3.01%
|
$2,415,150
$150.46 P/Share
|
|
Feb 13
2020
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
39,381
+6.89%
|
-
|
|
Feb 13
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
8,228
-3.62%
|
$1,234,200
$150.46 P/Share
|
|
Feb 13
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
16,084
+6.72%
|
-
|
|
Feb 13
2020
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,413
-3.12%
|
$1,411,950
$150.46 P/Share
|
|
Feb 13
2020
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,326
+6.34%
|
-
|
|
Feb 13
2020
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,091
-5.01%
|
$313,650
$150.46 P/Share
|
|
Feb 13
2020
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,080
+15.35%
|
-
|
|
Feb 13
2020
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,112
-5.58%
|
$1,066,800
$150.46 P/Share
|
|
Feb 13
2020
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,809
+11.4%
|
-
|
|
Feb 03
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
23,721
-19.22%
|
$3,534,429
$149.32 P/Share
|
|
Feb 03
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
48,312
+28.13%
|
-
|
|
Feb 03
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
15,405
-26.49%
|
$2,295,345
$149.32 P/Share
|
|
Feb 03
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
38,650
+39.93%
|
-
|
|
Jan 30
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Open market or private sale
|
Direct |
58,128
-54.07%
|
$8,661,072
$149.39 P/Share
|
|
Jan 30
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
58,128
+35.09%
|
$3,603,936
$62.62 P/Share
|